Concepedia

Rosiglitazone infusion therapy following minimally invasive surgery for intracerebral hemorrhage evacuation decreases matrix metalloproteinase-9 and blood–brain barrier disruption in rabbits

Guofeng Wu, Junjie Wu, Yu Jiao, Likun Wang, Fan Wang, Yingjun Zhang

BMC Neurology · 2015 · 24 citations · 26 references

DOIFull text

Open access

Abstract

RSG infusion therapy following MIS for ICH treatment might be more efficacious for reducing the levels of MMP-9 and secondary brain damage than MIS therapy alone.

References

26

Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone

David J. Graham, Rita Ouellet‐Hellstrom, Thomas MaCurdy et al. · JAMA · 2010 · 504 citations

Hematoma resolution as a target for intracerebral hemorrhage treatment: Role for peroxisome proliferator‐activated receptor γ in microglia/macrophages

Xiurong Zhao, Guanghua Sun, Jie Zhang et al. · Annals of Neurology · 2007 · 365 citations

Minimally Invasive Surgery Plus Recombinant Tissue-type Plasminogen Activator for Intracerebral Hemorrhage Evacuation Decreases Perihematomal Edema

W. Andrew Mould, J. Ricardo Carhuapoma, John Muschelli et al. · Stroke · 2013 · 356 citations · Full text

Stereotactic Treatment of Intracerebral Hematoma by Means of a Plasminogen Activator

Onno Teernstra, Silvia Evers, J. Lodder et al. · Stroke · 2003 · 301 citations · Full text

Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial

Timothy C. Morgan, Mario Zuccarello, Raj K. Narayan et al. · Acta neurochirurgica. Supplementum · 2009 · 247 citations

, , +9